Bio-Path Holdings, Inc. (BPTH) earnings
BPTH earnings moved a median of -4.50% by the close. Quarterly and annual BPTH reports and results, each read against the price at its own news timestamp. Back to the BPTH overview →
20 measured BPTH earnings events.
Where these BPTH earnings landedvs 20 measured BPTH earnings reactions
| Middle 50% of BPTH earnings reactions | -6.67% to -1.06% |
|---|---|
| Median reaction (to close) | -4.50% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 BPTH earnings events with a measured close landed between -6.67% and -1.06%; 5% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -19.77% | |
| Form NT 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form NT | — | +0.00% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Sep 30 | SEC filing · Form 10-Q | — | -5.47% | |
| Form NT 10-Q BIO-PATH HOLDINGS, INC. For: Sep 30 | SEC filing · Form NT | — | +0.00% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-Q | -7.69% | -5.13% | |
| Form 10-K BIO-PATH HOLDINGS, INC. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -11.31% | |
| Bio-Path Holdings Reports Third Quarter 2024 Financial Results | Press release | +0.00% | -16.24% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -16.24% | |
| Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024 | Press release | -1.00% | -0.67% | |
| Bio-Path Holdings Reports Second Quarter 2024 Financial Results | Press release | -1.90% | -3.87% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Jun 30 | SEC filing · Form 10-Q | -1.90% | -3.87% | |
| Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024 | Press release | — | +0.70% | |
| Bio-Path Holdings Reports First Quarter 2024 Financial Results | Press release | +11.67% | -6.67% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-Q | +11.67% | -6.67% | |
| Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024 | Press release | -1.70% | -6.44% | |
| Form 10-K BIO-PATH HOLDINGS INC For: Dec 31 | SEC filing · Form 10-K | -5.56% | -3.48% | |
| Bio-Path Holdings Reports Third Quarter 2023 Financial Results | Press release | -1.31% | -1.19% | |
| Form 10-Q BIO-PATH HOLDINGS INC For: Sep 30 | SEC filing · Form 10-Q | -1.31% | -1.19% | |
| Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023 | Press release | -3.22% | -6.22% |
Keep exploring
More BPTH: analyst actions → · SEC filings → · BPTH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ESSILOR LXTTCA UNSP/ADR (ESLOY) | 169 | -0.01% | 45% |
| BODY AND MIND INC (BMMJ) | 168 | 0.00% | 31% |
| Iterum Therapeutics plc - Ordinary Share (ITRM) | 168 | 0.00% | 49% |
| BIOSTAR PHARMS INC (BSPM) | 167 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.